Patents by Inventor Kimm Galbraith

Kimm Galbraith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7541355
    Abstract: Methods for the racemization of an enantiomer of a 2,3-benzodiazepine molecule into the corresponding racemic mixture under either basic or acidic conditions are described. Furthermore, the invention relates to the conversion of an enantiomer of tofisopam or its metabolites to the corresponding opposite enantiomer.
    Type: Grant
    Filed: May 23, 2005
    Date of Patent: June 2, 2009
    Assignee: Vela Acquisition Corporation
    Inventors: Yong Victoria Wei, Naidaong Ye, Kimm Galbraith, Jianfeng Shi, Wuyi Wang, Yungen Xu, Mallikarjun Reddy Ravi
  • Publication number: 20060264421
    Abstract: Methods for the racemization of an enantiomer of a 2,3-benzodiazepine molecule into the corresponding racemic mixture under either basic or acidic conditions are described. Furthermore, the invention relates to the conversion of an enantiomer of tofisopam or its metabolites to the corresponding opposite enantiomer.
    Type: Application
    Filed: May 23, 2005
    Publication date: November 23, 2006
    Applicant: Vela Pharmaceuticals, Inc.
    Inventors: Yong Wei, Naidong Ye, Kimm Galbraith, Jianfeng Shi, Wuyi Wang, Yungen Xu, Mallikarjun Ravi
  • Publication number: 20060128955
    Abstract: The present invention is directed to a process for the isolation of (R)-tofisopam with high enantiomeric purity and high overall yields from a mixture of tofisopam enantiomers by means of a non-steady state continuous chromatographic process.
    Type: Application
    Filed: December 15, 2005
    Publication date: June 15, 2006
    Applicant: Vela Pharmaceuticals, Inc.
    Inventors: Scott Perrin, Naidong Ye, Kimm Galbraith, Wilhelm Hauck